TRIM59 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.632600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.277400E-01
Normal-vs-Stage2
8.726000E-01
Normal-vs-Stage3
9.528600E-01
Normal-vs-Stage4
8.380800E-01
Stage1-vs-Stage2
2.548300E-02
Stage1-vs-Stage3
7.642000E-01
Stage1-vs-Stage4
2.673400E-01
Stage2-vs-Stage3
7.544400E-01
Stage2-vs-Stage4
9.176600E-01
Stage3-vs-Stage4
8.395000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.586000E-01
Normal-vs-AfricanAmerican
4.401000E-01
Normal-vs-Asian
9.469400E-01
Caucasian-vs-AfricanAmerican
3.189600E-01
Caucasian-vs-Asian
9.741200E-01
AfricanAmerican-vs-Asian
3.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.972200E-01
Normal-vs-Female
9.007000E-01
Male-vs-Female
6.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.291000E-01
Normal-vs-Age(41-60Yrs)
7.367600E-01
Normal-vs-Age(61-80Yrs)
9.817200E-01
Normal-vs-Age(81-100Yrs)
8.640200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.223970E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.259600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.553200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.585400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.456200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.123000E-01
Normal-vs-Daily Drinker
7.826600E-01
Normal-vs-Weekly Drinker
7.480400E-01
Normal-vs-Occasional Drinker
7.071200E-01
Normal-vs-Social Drinker
8.996800E-01
Non Drinker-vs-Daily Drinker
9.163800E-01
Non Drinker-vs-Weekly Drinker
2.832600E-01
Non Drinker-vs-Occasional Drinker
2.109600E-01
Non Drinker-vs-Social Drinker
4.906200E-01
Daily Drinker-vs-Weekly Drinker
2.825000E-01
Daily Drinker-vs-Occasional Drinker
2.140600E-01
Daily Drinker-vs-Social Drinker
4.724800E-01
Weekly Drinker-vs-Occasional Drinker
9.526000E-01
Weekly Drinker-vs-Social Drinker
7.542800E-01
Occasional Drinker-vs-Social Drinker
6.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.770200E-01
Normal-vs-Grade 2
3.128200E-01
Normal-vs-Grade 3
4.045000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.808800E-04
Grade 1-vs-Grade 3
5.560500E-03
Grade 1-vs-Grade 4
9.770200E-01
Grade 2-vs-Grade 3
7.932400E-01
Grade 2-vs-Grade 4
3.128200E-01
Grade 3-vs-Grade 4
4.045000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.412400E-01
Normal-vs-NonDiabetic
9.177000E-01
Diabetic-vs-NonDiabetic
3.354200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.341400E-01
Normal-vs-NoPancreatitis
9.488200E-01
Pancreatitis-vs-NoPancreatitis
9.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.525400E-01
Normal-vs-N1
8.352600E-01
N0-vs-N1
8.554500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.878200E-01
Normal-vs-TP53-NonMutant
8.592000E-01
TP53-Mutant-vs-TP53-NonMutant
2.879600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
